Skip to main content

Kyntra Bio, Inc.

KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000921299

No open-market purchases or sales by Kyntra Bio, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $7.54M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Kyntra Bio, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Kyntra Bio, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Kyntra Bio, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Wettig ThaneCEO26,796Sep 9, 20267
DeLucia DavidChief Financial Officer4,355Sep 9, 20265
Edwards Jeffrey LDirector33,977Jun 17, 20261
Kauffman MichaelDirector–Jun 17, 20261
Schoeneck James ADirector39,666IndirectJun 17, 20261
Ho MaykinDirector31,501Jun 17, 20261
Chung ChristineSVP, CHINA OPERATIONS294,903Mar 7, 20250
Graham JuanCHIEF FINANCIAL OFFICER164,863Dec 9, 20240
Adib DeyaaChief Medical Officer82,123Jun 13, 20240
Brennan AoifeDirector27,947Jun 6, 20240
Lema GeraldDirector28,766Jun 6, 20240
Blaug SuzanneDirector29,594Jun 6, 20240
Cravatt BenjaminDirector28,736Jun 6, 20240
Eisner MarkEVP, Chief Medical Officer159,917Sep 8, 20230
Henderson Jeffrey WilliamDirector28,866Sep 6, 20230
Conterno Enrique AChief Executive Officer374,722Jul 10, 20230
Kearns Thomas F JrDirector39,764Sep 17, 20210
Cotroneo PatExecutive Advisor & Former CFO274,536Sep 9, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 19, 2026 (view filing)May 145 daysWettig ThaneCEOPPurchase+2.80K$7.09+$19.9K+11.5%27.2K afterAmended
Nov 17, 2025 (view filing)Nov 13-174 daysWettig ThaneCEOPPurchase+3.70K$9.12+$33.8K+17.4%24.9K after2 lots
Jul 2, 2025 (view filing)Jun 302 daysSchoeneck James ADirectorPPurchase+23.6K$5.07+$119.5K+146.4%39.7K after
Mar 25, 2025 (view filing)9:00 AM ETMar 241 dayWettig ThaneCEOPPurchase+145.0K$0.3494+$50.7K+36.4%543.3K after
Mar 24, 2025 (view filing)9:00 AM ETMar 20-214 daysSchoeneck James ADirectorPPurchase+300.0K$0.3501+$105.0K+406.9%373.7K after2 lots
Jun 13, 2024 (view filing)Jun 121 dayAdib DeyaaChief Medical OfficerPPurchase+22.1K$1.17+$25.9K+36.9%82.1K after
Mar 11, 2024 (view filing)Mar 74 daysWettig ThaneCEOPPurchase+50.0K$1.91+$95.5K+11.9%470.2K after
Sep 6, 2023 (view filing)Sep 15 daysHenderson Jeffrey WilliamDirectorSSale−2.00K$1.03−$2.06K−6.5%28.9K after10b5-1
Aug 8, 2023 (view filing)Aug 44 daysHenderson Jeffrey WilliamDirectorSSale−2.00K$1.91−$3.82K−6.1%30.9K after10b5-1
Jul 13, 2023 (view filing)Jul 112 daysHenderson Jeffrey WilliamDirectorSSale−2.00K$2.69−$5.38K−5.7%32.9K after10b5-1
Jul 10, 2023 (view filing)Jul 73 daysConterno Enrique AChief Executive OfficerSSale−1.88K$2.80−$5.26K−0.5%374.7K after
Jun 26, 2023 (view filing)Jun 233 daysWettig ThaneChief Commercial OfficerSSale−791$16.53−$13.1K−0.7%108.3K after
Jun 22, 2023 (view filing)Jun 715 daysWettig ThaneChief Commercial OfficerSSale−1.76K$17.04−$30.0K−1.6%109.1K afterAmended2 lots
Jun 15, 2023 (view filing)Jun 13-142 daysChung ChristineSVP, China OperationsSSale−12.5K$17.19−$214.9K−5.0%236.3K after3 lots10b5-1
Jun 9, 2023 (view filing)Jun 9Same dayCravatt BenjaminDirectorSSale−3.94K$17.17−$67.7K−12.1%28.7K after2 lots10b5-1
Jun 9, 2023 (view filing)Jun 9Same dayBrennan AoifeDirectorSSale−4.73K$17.19−$81.4K−14.5%27.9K after2 lots10b5-1
Jun 9, 2023 (view filing)Jun 9Same dayBlaug SuzanneDirectorSSale−8.52K$17.20−$146.6K−22.4%29.6K after2 lots10b5-1
Jun 9, 2023 (view filing)Jun 81 dayHo MaykinDirectorSSale−8.52K$17.44−$148.6K−21.3%31.5K after2 lots10b5-1
Jun 9, 2023 (view filing)Jun 9Same dayEdwards Jeffrey LDirectorSSale−7.89K$17.19−$135.6K−18.8%34.0K after2 lots10b5-1
Jun 9, 2023 (view filing)Jun 81 dayHenderson Jeffrey WilliamDirectorSSale−7.00K$17.46−$122.2K−16.7%34.9K after2 lots10b5-1
Jun 9, 2023 (view filing)Jun 72 daysSchoeneck James ADirectorSSale−7.10K$18.03−$128.0K−8.8%73.7K after10b5-1
Jun 9, 2023 (view filing)Jun 72 daysGraham JuanChief Financial OfficerSSale−1.78K$16.99−$30.3K−2.4%71.1K after2 lots
Jun 9, 2023 (view filing)Jun 72 daysChung ChristineSVP, China OperationsSSale−3.63K$17.04−$61.9K−1.4%248.8K after3 lots
Jun 9, 2023 (view filing)Jun 72 daysEisner MarkEVP, Chief Medical OfficerSSale−2.04K$17.04−$34.8K−1.2%162.9K after
Jun 9, 2023 (view filing)Jun 72 daysConterno Enrique AChief Executive OfficerSSale−8.90K$17.04−$151.6K−2.3%376.6K after2 lots
Jun 5, 2023 (view filing)Jun 23 daysEisner MarkEVP, Chief Medical OfficerSSale−1.09K$18.83−$20.5K−0.7%164.9K after
Apr 11, 2023 (view filing)Apr 101 dayConterno Enrique AChief Executive OfficerSSale−1.87K$19.52−$36.5K−0.5%383.0K after
Apr 6, 2023 (view filing)Apr 42 daysEisner MarkChief Medical OfficerSSale−9.18K$18.78−$172.4K−5.2%166.0K after
Apr 6, 2023 (view filing)Apr 42 daysChung ChristineSVP, China OperationsSSale−6.59K$18.78−$123.8K−2.5%252.5K after
Mar 24, 2023 (view filing)Mar 231 dayWettig ThaneChief Commercial OfficerSSale−905$18.71−$16.9K−0.8%110.7K after
Mar 23, 2023 (view filing)Mar 1013 daysConterno Enrique AChief Executive OfficerSSale−19.5K$20.20−$393.7K−4.8%384.9K afterAmended
Mar 10, 2023 (view filing)Mar 8-102 daysChung ChristineSVP, China OperationsSSale−16.0K$20.70−$330.4K−5.8%259.1K after3 lots
Mar 10, 2023 (view filing)Mar 8-102 daysEisner MarkChief Medical OfficerSSale−17.5K$20.60−$360.6K−9.1%175.2K after3 lots
Mar 10, 2023 (view filing)Mar 8-102 daysGraham JuanChief Financial OfficerSSale−7.66K$20.54−$157.4K−9.5%72.9K after4 lots
Mar 10, 2023 (view filing)Mar 8-102 daysWettig ThaneChief Commercial OfficerSSale−13.9K$20.63−$287.5K−11.1%111.6K after3 lots
Mar 6, 2023 (view filing)Mar 24 daysEisner MarkChief Medical OfficerSSale−1.19K$21.87−$26.0K−0.7%172.5K after
Jan 10, 2023 (view filing)Jan 64 daysConterno Enrique AChief Executive OfficerSSale−1.54K$19.95−$30.7K−0.5%295.5K after
Jan 4, 2023 (view filing)Dec 8, 202227 daysChung ChristineSVP, China OperationsSSale−2.60K$15.79−$41.0K−1.1%234.9K afterAmended
Dec 28, 2022 (view filing)Dec 235 daysWettig ThaneChief Commercial OfficerSSale−734$15.80−$11.6K−0.8%89.2K after
Dec 15, 2022 (view filing)Dec 9-126 daysGraham JuanChief Financial OfficerSSale−2.19K$14.64−$32.0K−4.4%48.0K afterAmended2 lots
Dec 15, 2022 (view filing)Dec 87 daysLateGraham JuanChief Financial OfficerSSale−5.74K$14.89−$85.5K−10.3%50.1K after2 lots
Dec 9, 2022 (view filing)Dec 81 dayWettig ThaneChief Commercial OfficerSSale−382$15.79−$6.03K−0.4%89.9K after
Dec 9, 2022 (view filing)Dec 81 dayConterno Enrique AChief Executive OfficerSSale−2.54K$15.79−$40.2K−0.8%297.0K after
Sep 17, 2021 (view filing)Sep 152 daysKearns Thomas F JrDirectorSSale−13.1K$11.58−$151.7K−24.8%39.8K after
Aug 30, 2021 (view filing)Aug 264 daysWettig ThaneChief Commercial OfficerPPurchase+3.10K$11.53+$35.7K+6.8%48.8K after